These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38151607)

  • 1. Survey of Japanese nephrologists' use of clinical practice guidelines for rapidly progressive glomerulonephritis.
    Takahashi-Kobayashi M; Sada KE; Kawashima S; Miyawaki Y; Nakazawa D; Furuichi K; Okada H; Narita I; Usui J
    Clin Exp Nephrol; 2024 Apr; 28(4):316-324. PubMed ID: 38151607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between Pathological Findings and the Usefulness of Clinical Guidelines for the Treatment of ANCA-Positive RPGN: A Retrospective Analysis.
    Yamada T; Kashiwagi T; Shimizu A; Tsuruoka S
    J Nippon Med Sch; 2018; 85(5):259-264. PubMed ID: 30464142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development of rapidly progressive glomerulonephritis associated with both antineutrophil cytoplasmic antibody-associated vasculitis and anti-glomerular basement membrane nephritis in the course of nontuberculous mycobacterium infection: a case report.
    Kato M; Wakiya R; Kameda T; Inoue K; Sofue T; Ushio Y; Sugihara K; Nakashima S; Shimada H; Mansour MMF; Kadowaki N; Dobashi H
    BMC Rheumatol; 2020 Dec; 4(1):68. PubMed ID: 33308324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology and temporal changes in the prognosis of rapidly progressive glomerulonephritis in Japan: a nationwide 1989-2015 survey.
    Kaneko S; Yamagata K; Usui J; Tsuboi N; Sugiyama H; Maruyama S; Narita I
    Clin Exp Nephrol; 2022 Mar; 26(3):234-246. PubMed ID: 34643841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual myeloperoxidase-antineutrophil cytoplasmic antibody- and antiglomerular basement membrane antibody-positive cases associated with prior pulmonary fibrosis: a report of four cases.
    Nakabayashi K; Fujioka Y; Nagasawa T; Kimura T; Kojima K; Arimura Y; Yamada A
    Clin Exp Nephrol; 2011 Apr; 15(2):226-34. PubMed ID: 21246240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicoepidemiological manifestations of RPGN and ANCA-associated vasculitides: an 11-year retrospective hospital-based study in Japan.
    Suzuki Y; Takeda Y; Sato D; Kanaguchi Y; Tanaka Y; Kobayashi S; Suzuki K; Hashimoto H; Ozaki S; Horikoshi S; Tomino Y
    Mod Rheumatol; 2010 Feb; 20(1):54-62. PubMed ID: 19821007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rapid-detection GBM-ANCA ELISA. An emergency tool for the early diagnosis of type I and II rapidly progressive glomerulonephritis].
    Arranz O; Ara J; Rodríguez R; Poveda R; Serra A; Solé-Amigó J; Fort J; Mirapeix E; Darnell A
    Nefrologia; 2001; 21(4):349-54. PubMed ID: 11816510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent advances of clinical and basic research in rapidly progressive glomerulonephritis].
    Yamagata K; Koyama A
    Nihon Rinsho; 2001 Sep; 59(9):1837-46. PubMed ID: 11554061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-dependent survival in rapidly progressive glomerulonephritis: A nationwide questionnaire survey from children to the elderly.
    Takahashi-Kobayashi M; Usui J; Kaneko S; Sugiyama H; Nitta K; Wada T; Muso E; Arimura Y; Makino H; Matsuo S; Yamagata K
    PLoS One; 2020; 15(7):e0236017. PubMed ID: 32658915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapidly progressive glomerulonephritis in children.
    Moorani KN; Aziz M; Amanullah F
    Pak J Med Sci; 2022 Jan; 38(2):417-425. PubMed ID: 35310798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Rapidly Progressive Glomerulonephritis in the Elderly.
    Appel GB; Lau WL
    Blood Purif; 2018; 45(1-3):208-212. PubMed ID: 29478072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Rare Case of Double Antibody-Positive Rapidly Progressive Glomerulonephritis: A Therapeutic Challenge.
    Bell S; Lattanzio N; Abdelal Q; Teklie Y; Alkayali T; Wiese-Rometsch W; Sastry A
    J Investig Med High Impact Case Rep; 2021; 9():23247096211013193. PubMed ID: 33966476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apheresis for MPO-ANCA-associated RPGN-indications and efficacy: lessons learned from Japan nationwide survey of RPGN.
    Yamagata K; Hirayama K; Mase K; Yamaguchi N; Kobayashi M; Takahashi H; Koyama A
    J Clin Apher; 2005 Dec; 20(4):244-51. PubMed ID: 15880406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antineutrophil cytoplasmic antibody (ANCA) and rapidly progressive crescentic glomerulonephritis in Thai population.
    Sumethkul V; Changsirikulchai S; Radinahamed P; Chalermsanyakorn P
    Asian Pac J Allergy Immunol; 1999 Dec; 17(4):281-7. PubMed ID: 10698468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of rapidly progressive glomerulonephritis with anti-glomerular basement membrane antibody in the course of MPO-ANCA positive interstitial pneumonia].
    Yamazaki K; Kanehira K; Inaba Y; Shimizu J; Sugiyama N
    Nihon Jinzo Gakkai Shi; 2012; 54(8):1203-8. PubMed ID: 23387284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-glomerular basement membrane disease: Treatment outcome of cyclophosphamide vs. rituximab induction therapy regimen.
    Jaryal A; Vikrant S
    Clin Nephrol; 2022 Dec; 98(6):280-287. PubMed ID: 36282172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance of histopathological findings for predictive scoring of short-term treatment response to plasma exchange in severe ANCA-associated renal vasculitides.
    Hakroush S; Korsten P; Ströbel P; Tampe B
    Front Immunol; 2024; 15():1340999. PubMed ID: 38380320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous comprehensive multiplex autoantibody analysis for rapidly progressive glomerulonephritis.
    Sowa M; Trezzi B; Hiemann R; Schierack P; Grossmann K; Scholz J; Somma V; Sinico RA; Roggenbuck D; Radice A
    Medicine (Baltimore); 2016 Nov; 95(44):e5225. PubMed ID: 27858870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-glomerular basement membrane antibody disease in Japan: part of the nationwide rapidly progressive glomerulonephritis survey in Japan.
    Hirayama K; Yamagata K; Kobayashi M; Koyama A
    Clin Exp Nephrol; 2008 Oct; 12(5):339-347. PubMed ID: 18392773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-glomerular Basement Membrane Glomerulonephritis During the First Trimester of Pregnancy.
    Kai H; Usui J; Tawara T; Takahashi-Kobayashi M; Ishii R; Tsunoda R; Fujita A; Nagai K; Kaneko S; Morito N; Saito C; Hamada H; Yamagata K
    Intern Med; 2021 Mar; 60(5):765-770. PubMed ID: 32999239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.